BF
GSK icon

Blankinship & Foster’s GSK GSK Stock Holding History

Blankinship & Foster’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Hold
4,832
– – 0.05% 70
2026
Q1 		$267K Hold
4,832
– – 0.06% 66
2025
Q4 		$237K Hold
4,832
– – 0.05% 71
2025
Q3 		$209K Buy
+4,832
New +$189K 0.05% 76
2024
Q2 		– Sell
-5,443
Closed -$233K – 72
2024
Q1 		$233K Hold
5,443
– – 0.06% 61
2023
Q4 		$202K Buy
+5,443
New +$195K 0.06% 65

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Blankinship & Foster's GSK Position: Q2 2026 in Review

Blankinship & Foster held its GSK (GSK) position steady in Q2 2026 at 4,832 shares worth $253K. The position accounts for 0.05% of the portfolio, ranked #70.

Blankinship & Foster first reported a position in GSK in Q4 2023 and has held it in 6 quarters since. The position peaked at $267K in Q1 2026. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Blankinship & Foster held 4,832 shares of GSK worth $253K as of Q2 2026.
  • Blankinship & Foster left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.05% of Blankinship & Foster's portfolio in Q2 2026, its #70 holding.
  • Blankinship & Foster first reported a position in GSK in Q4 2023 and has held it in 6 quarters since.
  • Blankinship & Foster's GSK position peaked at $267K in Q1 2026.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Blankinship & Foster's 13F filing for Q2 2026, filed 31 Jul 2026.